Aging :: US businesses not prepared for aging workforce
More than a quarter of U.S. businesses have failed to plan for the effects of the aging American workforce, according to the results of a new national survey by researchers at Boston College.
College
Heart :: Schering-Plough announces clinical trial results for oral thrombin receptor antagonist
Schering-Plough Corporation announced today that results of the Phase II trial of its novel oral thrombin receptor antagonist (TRA) SCH 530348 will be presented at the 2007 annual Scientific Sessions of the American College of Cardiology (ACC.07)/Innovation in Intervention (i2) Summit, March 24-27 in New Orleans.
Heart Failure :: Cardiovascular protective benefits of carvedilol in heart failure patients
Patients with heart failure who received the heart medication carvedilol suffered fewer heart attacks and strokes and were less likely to die of these and other vascular events than patients prescribed another beta blocker, metoprolol tartrate, according to a retrospective analysis of COMET (the Carvedilol or Metoprolol European Trial) published in the March 6th issue of The Journal of the American College of Cardiology.
Heart :: Offspring whose parents have long lives appear to have lower heart risks in middle age
Individuals with one or more parents who survive to age 85 or older may have fewer risk factors for heart disease in middle age, according to a report in the March 12 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
PCOS :: Why Polycystic Ovary Syndrome and insulin resistance are so closely linked
Understanding the link between Polycystic Ovary Syndrome (PCOS) and insulin resistance is the aim of a new project announced today, funded by the charity WellBeing of Women.
Breast Cancer :: Study aims to find which breast cancer patients need chemotherapy
Most postmenopausal women with small breast tumors don?t need chemotherapy to reduce their recurrence risk after lumpectomy.
HIV :: Nevada scientist authors influential AIDS HIV paper
The decade-long research that University of Nevada, Reno College of Science Chemistry Professor Thomas Bell has invested in the development of an extremely effective HIV/AIDS-fighting compound received an important boost recently when one of Bell’s articles made the list of the 100 most influential publications in the HIV/AIDS research field for 2006.
Oral Health :: Routine screening for oral signs of disease can save lives
An assistant professor of dental hygiene at New York City College of Technology (City Tech), she is on a mission to educate her students and a variety of providers in the metropolitan New York area — hygienists, physicians, physician assistants, nurse practitioners and hospital HIV/AIDS counselors — to routinely conduct periodontal evaluations and oral cancer and vital sign screenings as well as how to recognize the clinical signs of such systemic diseases as HIV/AIDS.
Heart Disease :: Pfizer’s Lipitor for 5 new indications in patients with heart disease
Pfizer announced that the U.S. Food and Drug Administration (FDA) has approved Lipitor? (atorvastatin calcium) Tablets to reduce the risk of nonfatal heart attacks, fatal and non-fatal strokes, certain types of heart surgery, hospitalization for heart failure, and chest pain in patients with heart disease.
Distress :: Mental suffering of psychological torture equals to physical torture
Suffering may be said physical or mental, depending whether it refers to a feeling or emotion that is linked primarily to the body or to the mind. Forms of ill treatment during captivity that do not involve physical pain ? such as psychological manipulation, deprivation, humiliation and forced stress positions ? appear to cause as much mental distress and traumatic stress as physical torture.